2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Monday, October 8, 2018

1:15pm-2:45pm: Structural neural correlates of independent gait domains in Parkinson’s disease

J. Wilson, B. Galna, S. Lord, A. Yarnall, R. Lawson, G. Duncan, T. Khoo, D. Burn, L. Rochester, J.P. Taylor (Newcastle upon Tyne, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

N. Barad, C. Sankhla (Mumbai, India)

Parkinson's Disease: Non-Motor Symptoms · Hall 3FG

1:15pm-2:45pm: Study on Correlation between Serum Vitamin D Level and Cognition of Parkinson’s Disease

XY. Xu, J. Qian, XS. Huang, SY. Tian, D. Tong (Dalian, China)

Parkinson's Disease: Cognition · Hall 3FG

1:15pm-2:45pm: Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer

Z. Zeng, P. Miller, T. Graham, L. Tong, D. Hesk, W. Li, E. Hostetler (West Point, PA, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: Subcortical and Cortical 123I-FP-CIT binding deficits and mild cognitive impairment in Parkinson’s disease

A. Pilotto, F. Schiano DiCola, E. Premi, V. Garibotto, A. Scalvini, R. Turrone, R. Grasso, B. Bigni, S. Gipponi, B. Paghera, MC. Rizzetti, b. Borroni, A. Padovani (Brescia, Italy)

Parkinson's Disease: Cognition · Hall 3FG

1:15pm-2:45pm: Subjective and objective urinary dysfunction in parkinson’s disease and atypical parkinsonisms

Y. Lee, J. Kim (Seoul, Republic of Korea)

Parkinson's Disease: Non-Motor Symptoms · Hall 3FG

1:15pm-2:45pm: Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease

P. Huang, H.Y. Zhou, S.D. Chen (Shanghai, China)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: Substantia nigra hyperechogenicity is similarly enlarged in Gaucher and in GBA mutation carriers

D. Arkadir, A. Zimran (Jerusalem, Israel)

Parkinson's Disease: Pathophysiology · Hall 3FG

1:15pm-2:45pm: Substantia nigra T1 maps for the diagnosis of Parkinson’s disease

C. Juri, L. Tapia, J. Cruz, S. Uribe, M. Andia (Santiago, Chile)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG

1:15pm-2:45pm: Subthalamic Nucleus Local Field Potential Beta Activity in Chinese Advanced PD Patients

J. Wu, J. Li, C. Xu, S. Mei, Y. Zhang (Minneapolis, MN, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Hall 3FG